Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer

Published 2012 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer
Authors
Keywords
Adverse drug reactions, Cancer, Clinical practice, Concomitant medications, Irinotecan
Journal
International Journal of Clinical Oncology
Volume 18, Issue 4, Pages 735-742
Publisher
Springer Nature
Online
2012-05-25
DOI
10.1007/s10147-012-0425-5
References
View 2 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.